BCRX
#1832
BioCryst Pharmaceuticals, Inc. - Common Stock
9.9 0 USD
+0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+2.06%
Changement Mensuel
+10.00%
Evolution sur 6 mois
+14.45%
Changement Annuel
+18.28%
Clôture Précédente
9.7 0
Open
9.8 4
Low
9.8 4
High
9.9 3
Volume
368
Financials
- Market Capitalization 2.53 B
- Employee 435
- Founded 1986
- CEO Jon P. Stonehouse
- Website www.biocryst.com
- Headquarter Delaware, United States
- FIGI BBG000BLYWX6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.71
ratio cours/chiffre d'affaires
2.47
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1810 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 23.01 USD | -0.65% | -5.58% | +22.39% | +2.49% | 2.61 B USD | ||
| 1827 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.74 USD | +2.10% | -4.17% | +3.29% | -15.61% | 2.54 B USD | ||
| 1842 |  PGEN Precigen, Inc. - Common Stock | 6.93 USD | 0.00% | -6.73% | +11.24% | +54.34% | 2.48 B USD | ||
| 1846 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 34.25 USD | +0.50% | -2.42% | +7.64% | +15.16% | 2.47 B USD |